Li Wenliang, a face to the frontline healthcare worker? The first doctor to notify the emergence of the SARS-CoV-2 (COVID-19) outbreak by Petersen, E et al.
Journal Pre-proof
Li Wenliang, a face to the frontline healthcare worker? The first doctor to
notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
Eskild Petersen
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
David Hui
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Davidson H. Hamer
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Lucille Blumberg
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Lawrence C. Madoff
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Marjorie Pollack
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Shui Shan Lee
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Susan McLellan
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Ziad Memish
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Ira Praharaj
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Sean Wasserman
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Francine Ntoumi
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Esam Ibraheem Azhar
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Timothy D. Mchugh
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Richard Kock
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Guiseppe Ippolito
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Ali Zumla
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Marion Koopmans
PII: S1201-9712(20)30111-9
DOI: https://doi.org/10.1016/j.ijid.2020.02.052
Reference: IJID 3998
To appear in: International Journal of Infectious Diseases
Received Date: 25 February 2020
Please cite this article as: {doi: https://doi.org/
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2019 Published by Elsevier.
 1
Editorial 
Li Wenliang, a face to the frontline healthcare worker? The first doctor to notify the 
emergence of the SARS-CoV-2, (COVID-19), outbreak 
Eskild Petersena,b,c,* eskild.petersen@gmail.com 
aDirectorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman  
bEuropean Sociaty for Clinical Microbiology and Infectious Diseases, Basel, Switzerland  
cInstitute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark 
*Corresponding author at: Directorate General for Disease Surveillance and Control, Ministry 
of Health, Muscat, Oman. 
David Hui 
Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales 
Hospital, Shatin, New Territories, Hong Kong, China 
Davidson H. Hamera,b 
aDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA 
bSection of Infectious Disease, Department of Medicine, Boston University School of 
Medicine, Boston, MA, USA 
Lucille Blumberg 
Commented [AB1]: Your article is registered as a regular item 
and is being processed for inclusion in a regular issue of the journal. 
If this is NOT correct and your article belongs to a Special 
Issue/Collection please contact v.salter@elsevier.com immediately 
prior to returning your corrections. 
Commented [AB2]: Please check the presentation of author 
group and affiliations, and correct if necessary. 
Commented [AB3]: The author names have been tagged as 
given names and surnames (surnames are highlighted in teal color). 
Please confirm if they have been identified correctly. 
Commented [AB4]: Please check that the affiliations link the 
authors with their correct departments, institutions, and locations, 
and correct if necessary. 
Commented [AB5]: Please check the presentation of 
correspondence field, and correct if necessary. 
Commented [AB6]: Please confirm that the provided email 
address “eskild.petersen@gmail.com” is the correct address for 
official communication, else provide an alternate e-mail address to 
replace the existing one, because private e-mail addresses should not 
be used in articles as the address for communication. 
Jo
urn
al
Pre
-p
of
 2
National Institute for Communicable Diseases, A Division of the National Health Laboratory 
Service, Johannesburg, South Africa 
Lawrence C. Madoffa,b 
aInternational Society for Infectious Diseases, Boston, MA, USA  
bUniversity of Massachusetts, Division of Infectious Diseases, Worcester, MA, USA 
Marjorie Pollack  
International Society for Infectious Diseases, Boston, MA, USA 
Shui Shan Lee 0000-0003-1448-765X,  
Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, 
Shatin, Hong Kong, China 
Susan McLellan 
Biocontainment Treatment Unit, Biosafety for Research-Related Infectious Pathogens, 
University of Texas Medical Branch, Galveston, TX, USA 
Ziad Memisha,b,c 
aResearch Centre, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia  
bCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia  
Commented [AB7]: Please check the country name that has 
been inserted for the affiliations, and correct if necessary. 
Jo
ur
al 
Pre
-pr
oo
f
 3
cHubert Department of Global Health, Rollins School of Public Health, Emory University, 
Atlanta, GA, USA 
Ira Praharaj 
Indian Council of Medical Research, Department of Health Research, New Delhi, India 
Sean Wassermanq,  
qDivision of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur 
Hospital and University of Cape Town, Cape Town, South Africa 
Francine Ntoumi 
Fondation Congolaise pour la Recherche Médicale/Université Marien Ngouabi, Republic of 
Congo and Institute for Tropical Medicine, University of Tübingen, Germany 
Esam Ibraheem Azhar 
King Fahd Medical Research Center (KFMRC), Medical Laboratory Technology 
Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi 
Arabia 
Timothy D. Mchugh 
Center for Clinical Microbiology, Division of Infection and Immunity, University College 
London, United Kingdom 
Jo
ur
al 
Pr
-pr
oo
f
 4
Richard Kock 
The Royal Veterinary College, University of London, Hatfield, Hertfordshire, United 
Kingdom 
Guiseppe Ippolito 
Lazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy 
Ali Zumla 
Center for Clinical Microbiology, Division of Infection and Immunity, University College 
London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, 
London, United Kingdom 
Marion Koopmans 
Department of Viroscience, Erasmus Medical Center, University Medical Center, Rotterdam, 
Netherlands 
Dr Li Wenliang, who lost his life to the novel coronavirus, SARS-CoV-2, became the face of 
the threat of SARS-CoV-2 to frontline workers, the clinicians taking care of patients. Li, 34, 
was an ophthalmologist at Wuhan Central Hospital. On 30th December, 2019, when the 
Wuhan municipal health service sent out an alert, he reportedly warned a closed group of ex-
medical school classmates on the WeChat social media site of “Seven cases of severe acute 
Jo
urn
al
Pre
-pr
oo
f
 5
respiratory syndrome (SARS) like illness with links with the Huanan Seafood Wholesale 
Market” at his hospital. He was among eight people reprimanded by security officers for 
“spreading rumours”. In a tragic turn of events, he subsequently contracted SARS-CoV-2 
and, after a period in intensive care, died on the morning of Friday 7th February, 2020. 
This case is a stark reminder of the risks of emerging disease outbreaks for healthcare 
workers (HCWs). Dr Li Wenliang’s name is added to the long list of HCW that were at the 
forefront of outbreaks of SARS, Ebola, MERS and now SARS-CoV-2. It is important to 
recognise that it was the clinicians in Wuhan who sounded the alarm about the emergence of 
SARS-CoV-2 which was rapidly identified after these clinicians sent samples to a reference 
laboratory for next generation sequencing (NGS) (Zhou et al., 2020).  
Global public health security is of primary importance to prevent outbreaks of diseases with 
epidemic potential and every effort to detect, report, and institute infection prevention and 
control measures should be made. Astute clinicians, access to laboratories with state of the art 
tools, and openness, transparency and quick reporting are crucial components of this response 
(Kavanagh, 2020). This requires an open flow of information and collaboration between 
laboratory experts and clinicians on the frontline who may be the first to observe unusual Jo
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clustering of cases or uncommon clinical presentations, both of which should be reported 
immediately. 
Healthcare workers are also one of the groups most at risk from outbreaks due to reemerging 
and novel pathogens. This has been seen in the current SARS-CoV-2 outbreak in China 
where as many as 1716 health workers have been reported to be infected by the virus with 6 
deaths as on 14th February, 2020 (WHO, 2020a). In a single center case series of SARS-
CoV-2 from Wuhan published recently, almost 29% of all patients were healthcare workers 
presumed to have been infected in the hospital (Wang et al., 2020b). 
The preliminary sequence data on the case cluster were obtained by NGS of specimens 
collected on 26th December 2019 through 7 January 2020 (Lu et al., 2020). The Chinese 
authorities ruled out SARS-CoV and MERS-CoV, and confirmed a novel coronavirus as the 
probable cause on 9th January, 2020 (Hui et al., 2020; Wang et al., 2020a). The first genome 
sequence was released on virological.org the 12th January 2020, seventeen days after 
obtaining the first specimen and several additional genomic sequences were then shared on 
GISAID (Wang et al., 2020c). This is an impressive rapid progression from initial outbreak 
notification to identification of a novel pathogen. J
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The rapid identification of the SARS-CoV-2 virus by NGS illustrates the advances in 
molecular identification since the SARS-CoV (2003) and MERS-CoV (2012) outbreaks, 
where both viruses were initially identified by in vitro cell culture. Thus, clinician of the 
possibility of a new infectious disease coupled with NGS can serve to quickly identify novel 
pathogens and allow for the rapid initiation of control measures to reduce further spread and 
potentially prevent large-scale outbreaks.  
The SARS‐CoV outbreak originating from China in 2003 was first reported to the global 
health community by ProMED (ProMED, 2003; Carrion and Madoff, 2017; Hamer et al., 
2017). It took six weeks for the authorities to acknowledge the outbreak had spread 
significantly from Guangdong throughout China after cases were reported from Hong Kong, 
Hanoi, Singapore, and Toronto.  
In reporting the existence of a new respiratory disease to the WHO on December 31░st, the 
Chinese authorities formally acknowledged the outbreak much sooner this time, perhaps in 
part because of the ongoing spread of information on informal social media networks. 
ProMED posted the initial report of the unknown pneumonia outbreak in Wuhan on 30 
December 2019 (ProMED, 2019). Since then, transmission of information has been relatively 
transparent, with the prompt sharing of the sequence of the virus and actual numbers of cases 
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reported on a daily basis. The case figures have demonstrated the upward trajectory of the 
rapid spread of SARS-CoV-2 from Wuhan and Hubei Province to all of China.  
On 13th February 2020 the Chinese authorities changed the case definition and the number of 
newly reported cases over the prior 24░h jumped to 14,886 from a previous high of 4370 on 
6th February 2020. This was not a real increase, but reflected the addition of the cumulative 
number of clinically diagnosed cases (without laboratory confirmation) to the reported 
number of laboratory confirmed cases and demonstrates how easily a case definition can 
influence numbers. On 19 February 2020, the Chinese authorities changed the case definition 
to include laboratory confirmed cases only and designating clinically diagnosed cases as 
suspected cases. This resulted in a rapid drop of daily newly confirmed cases, again 
demonstrating the impact of case definition on reported case numbers. As of 23 February 
2020, WHO has reported a total of 78,007 cases with 2,462 deaths globally with reports of 
cases from 29 countries (WHO, 2020a,b). 
A key question remains “what is the real number of people infected since many cases may be 
mild or asymptomatic?” A recent modelling estimated the population attack rate to be 
between 0.75 per 100,000 to 15.8 per 100,000 analysing rates down to prefecture level in 
China (Yang et al., 2020). Any determination of incidence will likely be an underestimate 
J
urn
al 
Pre
-pr
oo
f
 9
since it will not include mild and asymptomatic cases. Accuracy of such estimates will 
depend on the development of sensitive and specific serologic tests. 
Recognizing disease in travelers is a particularly important aspect of surveillance for the 
importation of emerging infections. Multi-site collaborations such as the GeoSentinel 
Surveillance Network (Wilder‐Smith and Boggild, 2018) can act as sentinel systems to 
recognize new patterns of disease in travelers from specific areas. Previous GeoSentinel data 
showed that despite receiving care at specialized post-travel medicine sites, up to 40% of 
returning ill travellers with febrile illness do not have a confirmed etiology; frequently no 
specific diagnostic testing is available to identify a cause (Freedman et al., 2006; Wilson et 
al., 2007; Leder et al., 2013). The current large-scale outbreak of a novel pathogen, SARS-
CoV-2, highlights the critical importance of prioritizing the identification of disease etiology 
through clinician awareness and modern laboratory techniques such as NGS. 
There has been widespread mourning of the sad demise of Dr Li from COVID-2019. Dr Li 
Wenliang’s example as an astute clinician should inspire all of us to be vigilant, bold and 
courageous in reporting unusual clinical presentations. The SARS-CoV-2 outbreak 
underscores the responsibilities and the vulnerabilities of frontline health care workers in 
tackling novel and highly transmissible pathogens. We must use our knowledge and skills, 
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with the backup of laboratory support, to rapidly detect and report any suspicion of emerging 
infections. Rapid, transparent communication is paramount when infectious diseases emerge. 
This is the only way to prevent major outbreaks and will save many lives. 
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